About Amgen, Inc.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

At the moment the company generates 23395M USD in revenues.

On its last earning announcement, the company reported a profit of 13.02$ per share.

The book value per share is 23.03$

Amgen, Inc. website

Create a solid portfolio with AMGN

Add AMGN to your portfolio and optimize it!


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
23395M 82.10% 10008M 42.80% 8067M 13.02 5.67 133.10% 620M 23.03 9830M -655M 9175M